Keywords: introducing, biopharma, drugs, into, europe, cost-efficacy, studies

Introducing Biopharma Drugs Into Europe

Article | 17 April 1995

Print This

Cost-efficacy studies on new biopharmaceutical products should be a minor issue if the product is a major leap forward in ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in